LM, C., MC, B., C, C., W, O., B, M., A, A., . . . A, I. (2021). Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder. Annals of clinical and translational neurology, 8(1), 201. https://doi.org/10.1002/acn3.51269
Chicago Style (17th ed.) CitationLM, Chahine, et al. "Dopamine Transporter Imaging Predicts Clinically-defined α-synucleinopathy in REM Sleep Behavior Disorder." Annals of Clinical and Translational Neurology 8, no. 1 (2021): 201. https://doi.org/10.1002/acn3.51269.
MLA (9th ed.) CitationLM, Chahine, et al. "Dopamine Transporter Imaging Predicts Clinically-defined α-synucleinopathy in REM Sleep Behavior Disorder." Annals of Clinical and Translational Neurology, vol. 8, no. 1, 2021, p. 201, https://doi.org/10.1002/acn3.51269.